Synapse - Jamie Chaft

Results (293)

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers

Journal Article

Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma

Journal Article

Rekhtman, N.; Tafe, L. J.; Chaft, J. E.; Wang, L.; Arcila, M. E.; Colanta, A.; Moreira, A. L.; Zakowski, M. F.; Travis, W. D.; Sima, C. S.; more...
Modern Pathology (2013)

Fulltext@MSK | Save

EGFR exon 20 mutations: Molecular spectrum, incidence and clinicopathologic characteristics

Meeting Abstract

Liu, Y. C.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Reva, B.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Arcila, M. E.
Laboratory Investigation (2013)

Fulltext@MSK | Save

EGFR exon 20 mutations: Molecular spectrum, incidence and clinicopathologic characteristics

Meeting Abstract

Liu, Y. C.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Reva, B.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Arcila, M. E.
Modern Pathology (2013)

Fulltext@MSK | Save

EGFR exon 20 insertion mutations in lung adenocarcinomas: Prevalence, molecular heterogeneity, and clinicopathologic characteristics

Journal Article

Arcila, M. E.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Lau, C.; Reva, B. A.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Molecular Cancer Therapeutics (2013)

Fulltext@MSK | Save

Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers